Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hormos Licenses HMRlignan to Linnea - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Hormos Licenses HMRlignan to Linnea

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Hormos Medical Corporation, Turku, Finland, has licensed its dietary supplement ingredient HMRlignan to Linnea SA, Locarno, Switzerland. HMRlignan is a plant lignan, 7-hydroxymatairesinol, isolated and purified from Norway spruce (Picea abies). In humans, 7-hydroxyma­tairesinol is converted into mammalian lignan, enterolactone. HMRlignan is a highly purified lignan, which effectively elevates the enterolactone level already at milligram doses. In May 2004 Hormos obtained new dietary ingredient (NDI) clearance from the FDA, which allows HMRlignan-containing dietary supplements to be marketed in the U.S.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics